1. Home
  2. PLYX vs WEYS Comparison

PLYX vs WEYS Comparison

Compare PLYX & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PLYX

Polaryx Therapeutics Inc. Common Stock

N/A

Current Price

$5.45

Market Cap

262.3M

Sector

Health Care

ML Signal

N/A

Logo Weyco Group Inc.

WEYS

Weyco Group Inc.

HOLD

Current Price

$33.20

Market Cap

280.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLYX
WEYS
Founded
2014
1906
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
262.3M
280.9M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
PLYX
WEYS
Price
$5.45
$33.20
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
2.0M
17.1K
Earning Date
01-01-0001
03-03-2026
Dividend Yield
N/A
3.40%
EPS Growth
N/A
N/A
EPS
N/A
2.41
Revenue
N/A
$276,169,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$13.28
Revenue Growth
N/A
N/A
52 Week Low
$2.20
$25.51
52 Week High
$8.15
$34.83

Technical Indicators

Market Signals
Indicator
PLYX
WEYS
Relative Strength Index (RSI) 52.51 54.08
Support Level $2.37 $28.64
Resistance Level $7.43 $34.06
Average True Range (ATR) 1.11 1.46
MACD 0.22 -0.01
Stochastic Oscillator 59.79 68.12

Price Performance

Historical Comparison
PLYX
WEYS

About PLYX Polaryx Therapeutics Inc. Common Stock

Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small molecule drug candidates designed to address core pathological mechanisms common to LSDs.

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.

Share on Social Networks: